1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (954)
  2. Meeting Abstract (771)
  3. Book Section (42)
  4. Editorial (32)
  5. Review (26)
  6. Research Letter (15)
  7. Guidelines (6)
  8. Correspondence (5)
  9. Conference Paper (4)
  10. Miscellaneous (3)
  11. Book Whole (2)
Groups
  1. Department of Medicine (1860)
  2. Melanoma and Immunotherapeutics Service (1860)
  3. Solid Tumor Oncology Division (1860)
  4. GSK Faculty (1050)
  5. Melanoma Disease Management Team (782)
  6. Hematologic Malignancies, Division of (507)

More Groups

People
  1. Jedd Wolchok (905)
  2. Taha Merghoub (364)
  3. Michael Postow (361)
  4. Paul Chapman (326)
  5. Alexander Shoushtari (244)
  6. Margaret Callahan (197)

More People

Years
  1. 2025 (22)
  2. 2024 (46)
  3. 2023 (66)
  4. 2022 (125)
  5. 2021 (112)
  6. 2020 (122)

More Years

Publications
  1. Journal of Clinical Oncology (330)
  2. Journal for ImmunoTherapy of Cancer (131)
  3. Cancer Research (106)
  4. Clinical Cancer Research (90)
  5. Annals of Oncology (77)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (43)

More Publications

Publishers
  1. American Society of Clinical Oncology (342)
  2. American Association for Cancer Research (274)
  3. Biomed Central Ltd (148)
  4. Elsevier Inc. (144)
  5. Oxford University Press (109)
  6. Nature Publishing Group (88)

More Publishers

Results (1860)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Case report: Later onset of NRAS-mutant metastatic melanoma in a patient with a partially-excised giant congenital melanocytic nevus
    Journal Article

    Costa, B. A.; Zibara, V.; Singh, V.; Hamid, O.; Gandhi, S.; Moy, A. P.; Betof Warner, A. S.
    Frontiers in Medicine (2022)

    Fulltext@MSK | Save
  • Phase II randomized study comparing proton craniospinal irradiation with photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis
    Meeting Abstract

    Yang, J. T.; Wijetunga, N. A.; Pentsova, E.; Wolden, S. L.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Warner, A. B.; Yu, H. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Capturing uveal melanoma (UM) global practice patterns and clinical outcomes in the collaborative ocular melanoma natural history (OMNi) study (NCT04588662)
    Meeting Abstract

    Sacco, J. J.; Orloff, M. M.; Patel, S. P.; Conway, M.; Lim, L. A.; Fog, L. S.; Sia, D.; McKenzie, J.; McKay, D.; O'Day, R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Overall survival (OS) in metastatic uveal melanoma: A summary of recent prospective trials
    Meeting Abstract

    Piulats, J. M.; Shoushtari, A. N.; Ochsenreither, S.; Abdullah, S. E.; Holland, C.; McCully, M. L.; Baurain, J. F.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Assessing PD-L1 without a biopsy and through PD-L1 PET imaging with 18F-BMS-986229
    Meeting Abstract

    Postow, M. A.; Mauguen, A.; Frosina, D.; Jungbluth, A. A.; Busam, K. J.; Pandit Taskar, N.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Updated overall survival (OS) data from the phase 1b study of tebentafusp (tebe) as monotherapy or combination therapy with durvalumab (durva) and/or tremelimumab (treme) in metastatic cutaneous melanoma (mCM)
    Meeting Abstract

    Middleton, M. R.; Hamid, O.; Shoushtari, A. N.; Meier, F. E.; Bauer, T. M.; Salama, A. K. S.; Kirkwood, J. M.; Ascierto, P. A.; Lorigan, P.; Mauch, C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development
    Meeting Abstract

    Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer
    Meeting Abstract

    Lattanzi, M.; Solovyov, A.; Lihm, J.; Quinlan, C.; Whiting, K.; Li, H.; Al-Ahmadie, H. A.; Teo, M. Y.; Aggen, D. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Early quality of life (QOL) and symptom analysis from the DREAMseq phase III randomized control trial of combination immunotherapy versus targeted therapy in patients (pts) with BRAF-mutant metastatic melanoma (MM) (ECOG-ACRIN EA6134)
    Meeting Abstract

    Jensen, R. E.; Zheng, Y.; Atkins, M. B.; Chmielowski, B.; Tarhini, A. A.; Truong, T. G.; Davar, D.; O'Rourke, M. A.; Curti, B. D.; Brell, J. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term survival in advanced melanoma for patients treated with nivolumab plus ipilimumab in CheckMate 067
    Meeting Abstract

    Hodi, F. S.; Chiarion-Sileni, V.; Lewis, K. D.; Grob, J. J.; Rutkowski, P.; Lao, C. D.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save